Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Systemic Sclerosis Clinical Trials

34 recruiting trials for Systemic Sclerosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
34
Total Trials
34
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT07295847

A Study of AZD0120 in Autoimmune Diseases

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult...

Sponsor: AstraZenecaEnrolling: 2718 locations
RECRUITINGPhase 2NCT03630211

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published...

Sponsor: Paul SzabolcsEnrolling: 83 locations
RECRUITINGEarly Phase 1NCT07246096

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of...

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are...

Sponsor: Changhai HospitalEnrolling: 601 location
RECRUITINGPhase 1NCT05869955

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases...

The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases...

Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyEnrolling: 27020 locations
RECRUITINGNCT03473912

Meir Medical Center Rheumatologic Biobank

Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research,...

Sponsor: Meir Medical CenterEnrolling: 5001 location
RECRUITINGNCT06361745

Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Main purpose: To evaluate the safety of UTAA09 injection in the treatment of relapsed/refractory (R/R) autoimmune disease (AID). Secondary purpose: To evaluate the...

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.Enrolling: 101 location
RECRUITINGPhase 1NCT07085104

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults...

This is a first-in-human, single-arm, open-label study evaluating the safety, tolerability, and preliminary efficacy of ALLO-329 in adults with autoimmune diseases: systemic lupus...

Sponsor: Allogene TherapeuticsEnrolling: 5410 locations
RECRUITINGNCT06462768

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

Systemic SClerosis (SSC) is a systemic disease characterized by limited or diffuse cutaneous sclerosis, microangiopathy, overproduction of autoantibodies and variable organ damage...

Sponsor: CHU de ReimsEnrolling: 2601 location
RECRUITINGPhase 2NCT05029336

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

A subset of autoimmune diseases (ADs) in children and young adults are life-threatening and unresponsive to conventional treatments. In these patients, the delivery of high dose...

Sponsor: Stephan Grupp MD PhDEnrolling: 201 location
RECRUITINGNCT04334031

Deployment o the Multidisciplinary Prospective Cohort Imminent

Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life...

Sponsor: University Hospital, LilleEnrolling: 22001 location
RECRUITINGPhase 2NCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

The goal of this pilot study is to assess the feasibility of a larger study on the efficacy of mycophenolate mofetil in people diagnosed with systemic sclerosis with mild lung...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 353 locations
RECRUITINGNCT05345795

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. In patients with systemic sclerosis, interstitial lung...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 6001 location
RECRUITINGNCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

This study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis. It will allow the constitution of an organized collection of longitudinal...

Sponsor: University Hospital, BrestEnrolling: 1001 location
RECRUITINGNCT07012655

Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis Patients

In the current study we aim to assess the macrovascular involvement in SSc patients through an ultrasound (US) evaluation of radial and ulnar arteries and splanchnic vessels.

Sponsor: Assiut UniversityEnrolling: 501 location
RECRUITINGNCT05533034

Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease

Systematic sclerosis (SSc) is a potentially severe disease characterized by various visceral involvements including lung. The investigators hypothesize that a respiratory...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 151 location
RECRUITINGPhase 2NCT03582800

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

Ectopic soft tissue calcifications or ossifications can complicate the course of numerous diseases; most of them are rare or very rare. Even if the clinical, radiological and...

Sponsor: University Hospital, LimogesEnrolling: 408 locations
RECRUITINGPhase 2NCT07047690

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

The main purpose of the study is to investigate the efficacy on cutaneous thickness and the safety of Nemolizumab in adult patients with systemic sclerosis after a 52-week...

Sponsor: Galderma R&DEnrolling: 1623 locations
RECRUITINGPhase 2 / Phase 3NCT05098704

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

Systemic sclerosis (SSc) is a severe autoimmune disease associating dysimmunity, vasculopathy and fibrosis. No curative treatment is available. Pre-clinical abnormalities can be...

Sponsor: University Hospital, BordeauxEnrolling: 9010 locations
RECRUITINGPhase 1 / Phase 2NCT06733935

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019...

Sponsor: Nkarta, Inc.Enrolling: 14415 locations
RECRUITINGPhase 1 / Phase 2NCT06350110

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

This study is a preliminary investigation, with a single-group design, not randomized and transparent, focusing on treatment. Its purpose is to identify the highest dose of BH002...

Sponsor: Essen BiotechEnrolling: 751 location
RECRUITINGPhase 1 / Phase 2NCT06347718

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

The investigational product is designed to effectively combat B cells in patients with autoimmune diseases. Autologous T cells enriched with CD4/CD8 are genetically engineered...

Sponsor: Miltenyi Biomedicine GmbHEnrolling: 241 location
RECRUITINGPhase 4NCT06546540

The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis

Systemic sclerosis (SSc) is a chronic, multisystem autoimmune disease characterized by potentially widespread and progressive skin fibrosis and vascular abnormalities, and may...

Sponsor: Peking University Third HospitalEnrolling: 201 location
RECRUITINGPhase 1NCT06925542

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune...

Sponsor: CRISPR TherapeuticsEnrolling: 808 locations
RECRUITINGPhase 1 / Phase 2NCT06947460

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

This is a single-center, open-label, non-randomized, single-arm clinical trial. Patients with refractory lupus neritis (SLE-LN), systemic sclerosis (SSc), and primary Sjogren...

Sponsor: Beijing GoBroad HospitalEnrolling: 451 location
RECRUITINGPhase 2NCT04789850

Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis

The purpose of this study is to determine whether itacitinib is safe and effective in the treatment of systemic sclerosis in adults.

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 7420 locations
RECRUITINGPhase 1NCT06316076

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

To evaluate the safety and efficacy of CD19-CAR-DNT cells in subjects with relapsed/refractory autoimmune diseases

Sponsor: RenJi HospitalEnrolling: 481 location
RECRUITINGPhase 1NCT06414135

Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis

Relma-cel is a product containing CD19-CAR-transduced T cells. The purpose of this study is to evaluate the safety of Relma-cel at different dose levels in patients with early...

Sponsor: Liangjing LuEnrolling: 61 location
RECRUITINGPhase 2NCT04356755

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

Ischemic digital ulcers (DUs) are a frequent complication in systemic sclerosis with a major impact on hand function and quality of life. Digital injection of cultured...

Sponsor: University Hospital, ToulouseEnrolling: 327 locations
RECRUITINGNCT05505617

Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

To date, two devices to measure nitric oxide lung diffusing capacity (DLNO) are commercially available in Europe. Previous research has shown systematic between-device differences...

Sponsor: Holger DresselEnrolling: 231 location
RECRUITINGPhase 1 / Phase 2NCT06328777

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects...

RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis

Sponsor: Cabaletta BioEnrolling: 1210 locations
RECRUITINGNCT05273138

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

The pathophysiology of systemic sclerosis (SSc) is still poorly understood and there are no effective treatments for this disease. SSc is a heterogeneous disease with varying...

Sponsor: University Hospital, LilleEnrolling: 401 location
RECRUITINGPhase 1 / Phase 2NCT03211793

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of...

Sponsor: UMC UtrechtEnrolling: 201 location
RECRUITINGPhase 1NCT05016804

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Systemic...

Sponsor: The Foundation for Orthopaedics and Regenerative MedicineEnrolling: 202 locations
RECRUITINGNCT04402086

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Sponsor: Yale UniversityEnrolling: 50001 location